OCX stock is plunging Wednesday. Why? The more than 30% drop occurred after OncoCyte Corporation (NYSE:OCX) provided a mid-year update, which principally discussed the company’s CLIA Validation study of DetermaVu™.
Here’s what we …
MicroSmallCap offers you up-to-date, high quality news and information on the small cap companies that matter. Stay informed on current investing news and trends across the markets.
• Advertise with MicroSmallCap
• Write for MicroSmallCap
• Submit your Company News
Copyright © 2019 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767
#170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767